Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $741.0.

  • Lemaitre Vascular's Gains from Investment Securities changed N/A to $741.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $741.0, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 4149.69% up from last year.
  • As of Q3 2025, Lemaitre Vascular's Gains from Investment Securities stood at $741.0.
  • In the past 5 years, Lemaitre Vascular's Gains from Investment Securities ranged from a high of $6.0 million in Q4 2023 and a low of -$2.4 million during Q4 2024
  • Over the past 5 years, Lemaitre Vascular's median Gains from Investment Securities value was $1322.0 (recorded in 2022), while the average stood at $834811.0.
  • In the last 5 years, Lemaitre Vascular's Gains from Investment Securities surged by 10379.36% in 2023 and then crashed by 13949.35% in 2024.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Gains from Investment Securities stood at $3.5 million in 2021, then dropped by 15.8% to $2.9 million in 2022, then surged by 103.79% to $6.0 million in 2023, then tumbled by 139.49% to -$2.4 million in 2024, then skyrocketed by 100.03% to $741.0 in 2025.
  • Its last three reported values are $741.0 in Q3 2025, $741.0 for Q2 2025, and -$2.4 million during Q4 2024.